drugset / Trial / NCT01810770
Radium-223 Dichloride Asian Population Study in the Treatment of CRPC Patients With Bone Metastasis
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the safety and efficacy (Overall survival \[OS\]) of multiple doses of Ra-223 dichloride in an Asian population of subjects with CRPC metastatic to the bone.
Timeline
- Start
- 2013-03-26
- Primary completion
- 2017-09-25
- Completion
- 2017-09-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Radium-223 dichloride | Other / unclassified | 0.055 mbq/kg | Intravenous |